A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
To evaluate the efficacy and safety of SPH7485 tablets in patients with advanced solid tumors.
Eligibility Criteria
Inclusion Criteria: 1. Histologically or cytologically confirmed advanced solid tumors； 2. At least one extracranial measurable lesion; 3. ECOG (Eastern Cooperative Oncology Group) performance status score of 0 or 1; 4. Subjects whose laboratory examination indicators meet the prescribed standards during the screening period; 5. Life expectancy≥3 months; 6. Subjects whose toxic reactions to previous antitumor therapy returned to baseline or CTCAE≤grade 1; 7. Female subjects whose pregnancy tests are negative; Male subjects agree not to donate sperm; Subject and partner agree to use reliable contraception; 8. Volunteer to participate in clinical research; Fully understand and know the study and sign the informed consent; Subjects willing to follow and able to complete all test procedures. Exclusion Criteria: 1. Subjects who have received the prescribed other anti-tumor treatments at the prescribed time prior to the first dose; 2. Subjects who have received previous drugs with the same t